Pharmacists in 2023 – unlocking the future of pharmacy

A major new PSA report, Pharmacists in 2023, reveals a roadmap for the changes needed to ensure the profession’s potential is realised – and...

The challenges of implementing the VAD Act

As the date for implementation of the Voluntary Assisted Dying (VAD) Act moves closer, the development of clinical practices around the law is underway....

New alliance between PSA and SHPA announced

At PSA19 this morning, it was revealed that a Memorandum of Understanding (MoU) was signed by PSA and the Society of Hospital Pharmacists of...

NSW pharmacists given special authority to supply essential medicines

NSW has granted pharmacists a landmark special authority to supply most S4 medicines without a prescription to those affected by bushfires. The NSW Chief Health...

Systemic corticosteroids for dyspnoea

The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer. Dyspnoea affects almost 70% of advanced cancer patients at the...

Next gen ECP leaders introduced

PSA introduced the new crop of leaders for the ECP Community of Specialty Interest to empower the next generation of pharmacists.